healthstream inc. - HSTM
HSTM
Close Chg Chg %
34.59 0.57 1.65%
Closed Market
35.16
+0.57 (1.65%)
Volume: 205.97K
Last Updated:
Oct 23, 2026, 4:00 PM EDT
Company Overview: healthstream inc. - HSTM
HSTM Key Data
| Open $34.39 | Day Range 34.26 - 35.23 |
| 52 Week Range 19.50 - 35.23 | Market Cap $1.03B |
| Shares Outstanding 30.60M | Public Float 21.88M |
| Beta 0.42 | Rev. Per Employee N/A |
| P/E Ratio 46.68 | EPS $0.72 |
| Yield 39.32% | Dividend $0.04 |
| EX-DIVIDEND DATE Aug 17, 2026 | SHORT INTEREST N/A |
| AVERAGE VOLUME 188.33K |
HSTM Performance
| 1 Week | 6.13% | ||
| 1 Month | 20.82% | ||
| 3 Months | 29.57% | ||
| 1 Year | 33.64% | ||
| 5 Years | 32.13% |
HSTM Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
6
Full Ratings ➔
About healthstream inc. - HSTM
HealthStream, Inc. engages in the provision of services to healthcare organizations. It develops healthcare technology platforms for workforce solutions. The firm’s workforce solutions include learning management, nurse & staff scheduling, clinical education, credentialing, privileging, provider enrollment, performance assessment, and managing simulation-based education programs. The company was founded by Robert A. Frist, Jr. and Jeffery L. McLaren in 1990 and is headquartered in Nashville, TN.
HSTM At a Glance
HealthStream, Inc.
500 11th Avenue North
Nashville, Tennessee 37203-2015
| Phone | 1-615-301-3100 | Revenue | 304.06M | |
| Industry | Packaged Software | Net Income | 18.34M | |
| Sector | Technology Services | 2025 Sales Growth | 4.258% | |
| Fiscal Year-end | 12 / 2026 | Employees | 1,160 | |
| View SEC Filings |
HSTM Valuation
| P/E Current | 46.684 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 37.913 |
| Price to Sales Ratio | 2.287 |
| Price to Book Ratio | 1.928 |
| Price to Cash Flow Ratio | 10.98 |
| Enterprise Value to EBITDA | 10.296 |
| Enterprise Value to Sales | 2.157 |
| Total Debt to Enterprise Value | 0.027 |
HSTM Efficiency
| Revenue/Employee | 262,124.138 |
| Income Per Employee | 15,812.069 |
| Receivables Turnover | 7.797 |
| Total Asset Turnover | 0.576 |
HSTM Liquidity
| Current Ratio | 0.964 |
| Quick Ratio | 0.964 |
| Cash Ratio | 0.459 |
HSTM Profitability
| Gross Margin | 50.442 |
| Operating Margin | 6.655 |
| Pretax Margin | 7.636 |
| Net Margin | 6.032 |
| Return on Assets | 3.476 |
| Return on Equity | 5.142 |
| Return on Total Capital | 4.936 |
| Return on Invested Capital | 4.921 |
HSTM Capital Structure
| Total Debt to Total Equity | 4.965 |
| Total Debt to Total Capital | 4.73 |
| Total Debt to Total Assets | 3.30 |
| Long-Term Debt to Equity | 4.148 |
| Long-Term Debt to Total Capital | 3.952 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Healthstream Inc. - HSTM
Collapse All in section
| All values USD millions. | 2022 | 2023 | 2024 | 2025 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 266.83M | 279.06M | 291.65M | 304.06M | |
Sales Growth
| +3.94% | +4.59% | +4.51% | +4.26% | |
Cost of Goods Sold (COGS) incl D&A
| 129.09M | 136.10M | 139.18M | 150.69M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 37.95M | 41.08M | 41.24M | 43.48M | |
Depreciation
| 4.50M | 4.20M | 3.80M | 3.90M | |
Amortization of Intangibles
| 33.45M | 36.88M | 37.44M | 39.58M | |
COGS Growth
| +0.97% | +5.43% | +2.26% | +8.27% | |
Gross Income
| 137.74M | 142.97M | 152.47M | 153.38M | |
Gross Income Growth
| +6.88% | +3.80% | +6.65% | +0.60% | |
Gross Profit Margin
| +51.62% | +51.23% | +52.28% | +50.44% |
| 2022 | 2023 | 2024 | 2025 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 125.29M | 126.95M | 131.18M | 133.14M | |
Research & Development
| 44.28M | 45.54M | 48.89M | 50.98M | |
Other SG&A
| 81.01M | 81.41M | 82.29M | 82.16M | |
SGA Growth
| +3.71% | +1.32% | +3.33% | +1.49% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| - | - | - | (2.85M) | - |
EBIT after Unusual Expense
| 15.30M | 16.02M | 21.29M | 20.24M | |
Non Operating Income/Expense
| 287.00K | 2.49M | 3.52M | 2.98M | |
Non-Operating Interest Income
| - | - | 3.83M | 3.34M | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| - | - | - | - | - |
Interest Expense Growth
| - | - | - | - | - |
Gross Interest Expense
| - | - | - | - | - |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 15.59M | 18.51M | 24.80M | 23.22M | |
Pretax Income Growth
| +100.68% | +18.77% | +33.99% | -6.39% | |
Pretax Margin
| +5.84% | +6.63% | +8.50% | +7.64% | |
Income Tax
| 3.49M | 3.30M | 4.80M | 4.88M | |
Income Tax - Current - Domestic
| 2.90M | 5.01M | 5.90M | (258.00K) | |
Income Tax - Current - Foreign
| (110.00K) | 15.00K | 14.00K | 17.00K | |
Income Tax - Deferred - Domestic
| 734.00K | (1.71M) | (1.05M) | 5.24M | |
Income Tax - Deferred - Foreign
| (25.00K) | (18.00K) | (64.00K) | (122.00K) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 12.09M | 15.21M | 20.01M | 18.34M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 12.09M | 15.21M | 20.01M | 18.34M | |
Net Income Growth
| +106.86% | +25.82% | +31.51% | -8.32% | |
Net Margin Growth
| +4.53% | +5.45% | +6.86% | +6.03% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 12.09M | 15.21M | 20.01M | 18.34M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 12.09M | 15.21M | 20.01M | 18.34M | |
EPS (Basic)
| 0.3945 | 0.4976 | 0.6584 | 0.611 | |
EPS (Basic) Growth
| +112.78% | +26.13% | +32.32% | -7.20% | |
Basic Shares Outstanding
| 30.65M | 30.57M | 30.39M | 30.02M | |
EPS (Diluted)
| 0.3936 | 0.496 | 0.655 | 0.6085 | |
EPS (Diluted) Growth
| +112.87% | +26.02% | +32.06% | -7.10% | |
Diluted Shares Outstanding
| 30.72M | 30.67M | 30.54M | 30.14M | |
EBITDA
| 50.39M | 57.09M | 62.53M | 63.71M | |
EBITDA Growth
| +12.32% | +13.30% | +9.52% | +1.89% | |
EBITDA Margin
| +18.89% | +20.46% | +21.44% | +20.95% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 35.00 | |
| Number of Ratings | 6 | Current Quarters Estimate | 0.147 | |
| FY Report Date | 12 / 2026 | Current Year's Estimate | 0.737 | |
| Last Quarter’s Earnings | 0.16 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 0.61 | Next Fiscal Year Estimate | 0.837 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 6 | 4 | 6 | 6 |
| Mean Estimate | 0.15 | 0.21 | 0.74 | 0.84 |
| High Estimates | 0.17 | 0.21 | 0.76 | 0.89 |
| Low Estimate | 0.11 | 0.20 | 0.71 | 0.79 |
| Coefficient of Variance | 13.41 | 2.82 | 2.38 | 4.25 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 2 | 2 | 2 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 4 | 3 | 3 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Healthstream Inc. - HSTM
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Healthstream Inc. - HSTM
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Sep 30, 2026 | Jennifer H. Lopresto Senior Vice President | 439 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Sep 30, 2026 | Michael M. Collier Executive Vice President | 2,198 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Sep 30, 2026 | Michael M. Collier Executive Vice President | 1,664 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Sep 30, 2026 | Michael M. Collier Executive Vice President | 1,230 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Sep 30, 2026 | Michael M. Collier Executive Vice President | 61,771 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $29.1 per share | 1,797,536.10 |
| Sep 30, 2026 | Michael M. Collier Executive Vice President | 62,248 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Sep 30, 2026 | Michael Scott McQuigg Senior Vice President | 1,759 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Sep 30, 2026 | Michael Scott McQuigg Senior Vice President | 1,331 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Sep 30, 2026 | Michael Scott McQuigg Senior Vice President | 984 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Sep 30, 2026 | Michael Scott McQuigg Senior Vice President | 36,374 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 | 0.00 |
| Sep 30, 2026 | Michael Scott McQuigg Senior Vice President | 36,755 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Sep 30, 2026 | Robert A. Frist CEO and Chairman; Director | 3,908,993 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Sep 30, 2026 | Kevin P. O'Hara Executive Vice President | 2,198 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Sep 30, 2026 | Kevin P. O'Hara Executive Vice President | 1,331 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Sep 30, 2026 | Kevin P. O'Hara Executive Vice President | 984 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Sep 30, 2026 | Kevin P. O'Hara Executive Vice President | 22,224 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $29.1 per share | 646,718.40 |
| Sep 30, 2026 | Kevin P. O'Hara Executive Vice President | 22,624 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Sep 30, 2026 | Robert A. Frist CEO and Chairman; Director | 2,198 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Sep 30, 2026 | Robert A. Frist CEO and Chairman; Director | 1,664 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Sep 30, 2026 | Robert A. Frist CEO and Chairman; Director | 1,230 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |